Our ethics and compliance program is founded on Eisai's human health care (hhc) mission: "We give our first thought to the patients and their families and to increasing the benefit health care provides." It is fundamental to our mission of being an hhc company that we comply with all laws that govern our businesses. It is an integral part of the hhc ideal that we achieve our corporate goals and implement our corporate mission on the basis of such compliance, and in accordance with the highest level of integrity, when our actions may affect the lives and health of many people. Eisai's reputation - for integrity, honesty, fairness, candor, and respect in all of its business dealings - is directly attributable to the highest ethical conduct of its directors, officers and employees.
As a statement of our commitment to ethics and compliance, Eisai has established a Charter of Business Conduct for all its affiliates throughout the world.
To further ensure that our directors, officers and employees exhibit integrity and a positive image that reflects our mission and values, Eisai has established a comprehensive, integrated compliance program for its United States operations, which is overseen by the Chief Ethics and Compliance Officer. Our Comprehensive Compliance Program (CCP) incorporates the elements of the United States Sentencing Commission "Guidelines for Organizations," the United States Department of Health and Human Services (HHS) Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Practitioners. Our CCP also complies with the requirements of Chapter 8, Section 119400 of the California Health and Safety Code. To view our Declaration of Compliance with California law, please click here. To view a summary of our CCP, please click here.
The responsibilities and activities of the Corporate Ethics and Compliance Department include the following:
Clinical Trials Disclosure
California Transparency in Supply Chains Act